Sponsor Dossier
Interpharma
Sponsor Dossier for Interpharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: APOMINE
- Brand: BORTEZOMIB EVER PHARMA
- Brand: CABAZITAXEL EVER PHARMA
- Brand: CARBETOCIN
- Brand: DEXMEDETOMIDINE EVER PHARMA
- Brand: EPHEDRINE
- Brand: ESMOLOL
- Brand: FULVESTRANT
- Device (sponsor): Infusion pump medication reservoir set
- Device (sponsor): Cartridge-accepting autoinjector, mechanical
- Device (sponsor): General-purpose infusion pump, battery-powered
- Device (sponsor): STAT-ON Parkinson's Holter - Neuromuscular motion disorder long-term ambulatory recorder/analyser
- Device (sponsor): D-mine Infusion Set - Electric infusion pump administration set
- Device (sponsor): Hypodermic needle, single-use, sterile
- Device (sponsor): Lavage handpiece tip
- Device (sponsor): Perioperative methylene blue stain
- Device (sponsor): Sentinel lymph node dye
- Device (sponsor): D-Mine Pump - General-purpose infusion pump, battery-powered
- Device (sponsor): Infusion pump cassette
- Device (sponsor): Instillagel Almed (Lignocaine 2% and Chlorhexidine 0.05%) - General-body orifice lubricant, sterile
- Device (sponsor): Basic insulin pen, replaceable-cartridge
- Device (sponsor): Instillagel Lido (Lignocaine 2%) - General-body orifice lubricant, sterile
- Device (sponsor): Endotherapy cannula, flexible, single-use
About
Interpharma is an Australian Private Company with ABN 19099877899, registered in New South Wales. The company is active and registered for GST from 2002.
Portfolio
Interpharma has 19 brands on the ARTG, of which 19 are indexable and 19 carry a Product Information document. 5 brands are PBS-listed, 4 have a PBAC outcome on record, and 1 has an AusPAR on record. Notable brands include APOMINE, BORTEZOMIB EVER PHARMA, CABAZITAXEL EVER PHARMA, CARBETOCIN, DEXMEDETOMIDINE EVER PHARMA, EPHEDRINE, ESMOLOL, FULVESTRANT, GENTAMICIN, Heparin, INSTILLAGEL, KETAMINE INTERPHARMA.
Therapeutic focus
— Oncology: 4 brands — Pain Management: 4 brands — Other: 3 brands — Infectious Disease: 2 brands — Neurology: 2 brands — Haematology: 1 brand — Hepatology: 1 brand — Reproductive Health: 1 brand — Cardiology: 1 brand
PBS footprint
5 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2023-03-01, across 4 brands with a PBAC outcome on record. The latest AusPAR is 2024-07-30, across 1 brand with an AusPAR on record.